SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 55.92 |
| Enterprise Value ($M) | 36.66 |
| Book Value ($M) | 16.55 |
| Book Value / Share | 0.46 |
| Price / Book | 3.38 |
| NCAV ($M) | 15.15 |
| NCAV / Share | 0.42 |
| Price / NCAV | 3.69 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.94 |
| Return on Assets (ROA) | -2.33 |
| Return on Equity (ROE) | -10.97 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.77 |
| Current Ratio | 1.77 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 35.90 |
| Assets | 37.29 |
| Liabilities | 20.75 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Lytton Laurence W | 9.99 | 33.83 | |
| 13G/A | ADAR1 Capital Management, LLC | 8.51 | ||
| 13G/A | Rosalind Advisors, Inc. | 9.90 | 35.51 | |
| 13G/A | Lincoln Park Capital Fund, LLC | 9.68 | 39.41 | |
| 13G | Nantahala Capital Management, LLC | 9.90 | ||
| 13G/A | Hirschman Orin | 8.70 | 39.01 | |
| 13G | ADAR1 Partners, LP | 6.21 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 301,136 | 1,342,114 | 22.44 | |
| 118,948 | 736,968 | 16.14 | |
| 640,173 | 1,746,864 | 36.65 | |
| 415,111 | 1,335,880 | 31.07 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CKPT – Checkpoint Therapeutics, Inc. | CLDX – Celldex Therapeutics, Inc. |
| CLNN – Clene Inc. | CMPX – Compass Therapeutics, Inc. |
| CNSP – CNS Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io